跳至主要内容
临床试验/NCT02904590
NCT02904590已完成不适用

A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease

Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa24 个研究点 分布在 1 个国家目标入组 1,204 人开始时间: 2016年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,204
试验地点
24
主要终点
The incidence of infection and type of infection in patients with ulcerative colitis and Crohn's disease, regardless of treatment received. ulcerative colitis and Crohn's disease, regardless of treatment received.

研究概览

简要总结

The purpose of this study is to determine the incidence and risk factors related to Infection in patients with Inflammatory Bowel Disease (IBD)

详细描述

IBD could lead to an increased risk of infections, particularly related to immunosuppressive therapy. The true effect of having IBD in the development of infections has not been studied in depth since the cohort studies are scarce and the results of studies with different approaches are contradictory.

The limited time period of former studies may not be enough to assess infectious complications that may occur in a long term period.

Moreover, certain polymorphisms demonstrated to confer a higher risk of opportunistic infections under immunosuppressive conditions, for instance HIV, patients with cystic fibrosis and Candida' infections. For this reason, it seems reasonable to think that genetic factors might play a role in the risk of opportunistic infections in IBD.

The hypothesis of this study is that patients with IBD have an increased risk of infection by immunosuppressive treatment.

TYPE OF STUDY Prospective cohort study that evaluates the effect of immunosuppression and other clinical factors in the onset of infection in IBD

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Year 至 100 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • HIV infection or any congenital immunodeficiency at the time of inclusion.
  • To be under any immunosuppressant therapy for another reason other than IBD at IBD diagnosis.
  • No consent to participate.

结局指标

主要结局

The incidence of infection and type of infection in patients with ulcerative colitis and Crohn's disease, regardless of treatment received. ulcerative colitis and Crohn's disease, regardless of treatment received.

时间窗: Change from baseline incidence and type of infection at 3 and 5 years

Serious infection means any untoward medical occurrence that at any dose: * Results in death or life-threatening * Requires in patient hospitalization or prolongation of an existing hospitalization * Is a medically important event. * Requires specific chemotherapy treatment * Emerges repeatedly. * Induces a switch or a withdrawal of the immunosuppressive or biological treatment

Clinical, demographic, epidemiologic and genetic factors associated with the risk of infection in patients with IBDassociated with the risk of infection in patients with IBD.

时间窗: Change from baseline and at 3 and 5 years

次要结局

  • The type of infections in IBD patients grouped by systems and whether they are opportunistic or not.(at baseline and at 3 and 5 years)
  • The effect of duration and immunosuppressive potency in the development of infections(at baseline and at 3 and 5 years)
  • The impact of infection on morbidity and mortality in patients with IBD.(at baseline and at 3 and 5 years)

研究者

发起方
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
申办方类型
Other
责任方
Sponsor

研究点 (24)

Loading locations...

相似试验